Annual CAPEX
N/A
December 1, 2024
Summary
- ADPT annual capital expenditures is not available.
Performance
ADPT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
December 1, 2024
Summary
- ADPT quarterly capital expenditures is not available.
Performance
ADPT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
December 1, 2024
Summary
- ADPT TTM capital expenditures is not available.
Performance
ADPT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ADPT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ADPT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Adaptive Biotechnologies CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $344.00 K(-80.1%) | $4.88 M(-33.3%) |
| Jun 2024 | - | $1.73 M(+14.4%) | $7.32 M(-21.2%) |
| Mar 2024 | - | $1.51 M(+16.4%) | $9.28 M(-13.2%) |
| Dec 2023 | $10.70 M(-34.6%) | $1.30 M(-53.3%) | $10.70 M(-10.4%) |
| Sep 2023 | - | $2.78 M(-24.9%) | $11.94 M(-18.2%) |
| Jun 2023 | - | $3.70 M(+26.4%) | $14.60 M(-9.9%) |
| Mar 2023 | - | $2.92 M(+15.0%) | $16.20 M(-0.9%) |
| Dec 2022 | $16.35 M(-73.5%) | $2.54 M(-53.2%) | $16.35 M(-29.1%) |
| Sep 2022 | - | $5.43 M(+2.5%) | $23.05 M(-28.5%) |
| Jun 2022 | - | $5.30 M(+72.2%) | $32.24 M(-34.2%) |
| Mar 2022 | - | $3.08 M(-66.7%) | $48.98 M(-20.7%) |
| Dec 2021 | $61.75 M | $9.24 M(-36.8%) | $61.75 M(-0.2%) |
| Sep 2021 | - | $14.62 M(-33.7%) | $61.87 M(+20.2%) |
| Jun 2021 | - | $22.04 M(+39.1%) | $51.46 M(+62.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $15.84 M(+69.1%) | $31.68 M(+68.5%) |
| Dec 2020 | $18.80 M(+67.9%) | $9.37 M(+122.7%) | $18.80 M(+58.7%) |
| Sep 2020 | - | $4.21 M(+85.9%) | $11.85 M(+7.0%) |
| Jun 2020 | - | $2.26 M(-23.6%) | $11.07 M(+7.2%) |
| Mar 2020 | - | $2.96 M(+22.6%) | $10.33 M(-7.8%) |
| Dec 2019 | $11.20 M(+77.8%) | $2.42 M(-29.6%) | $11.20 M(-0.7%) |
| Sep 2019 | - | $3.43 M(+125.2%) | $11.28 M(+12.4%) |
| Jun 2019 | - | $1.52 M(-60.2%) | $10.04 M(+5.3%) |
| Mar 2019 | - | $3.83 M(+53.5%) | $9.54 M(+51.4%) |
| Dec 2018 | $6.30 M(+151.4%) | $2.50 M(+13.9%) | $6.30 M(+65.6%) |
| Sep 2018 | - | $2.19 M(+114.7%) | $3.80 M(+135.7%) |
| Jun 2018 | - | $1.02 M(+71.7%) | $1.61 M(+171.7%) |
| Mar 2018 | - | $594.00 K | $594.00 K |
| Dec 2017 | $2.51 M | - | - |
FAQ
- What is the all time high annual CAPEX for Adaptive Biotechnologies?
- What is the all time high quarterly CAPEX for Adaptive Biotechnologies?
- What is the all time high TTM CAPEX for Adaptive Biotechnologies?
What is the all time high annual CAPEX for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual capital expenditures is $61.75 M
What is the all time high quarterly CAPEX for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly capital expenditures is $22.04 M
What is the all time high TTM CAPEX for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM capital expenditures is $61.87 M